325 related articles for article (PubMed ID: 28403088)
1. Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
Qiao YC; Chen YL; Pan YH; Ling W; Tian F; Zhang XX; Zhao HL
Medicine (Baltimore); 2017 Apr; 96(15):e6583. PubMed ID: 28403088
[TBL] [Abstract][Full Text] [Related]
2. Relationship between transforming growth factor-β1 and type 2 diabetic nephropathy risk in Chinese population.
Zhou T; Li HY; Zhong H; Zhong Z
BMC Med Genet; 2018 Nov; 19(1):201. PubMed ID: 30458730
[TBL] [Abstract][Full Text] [Related]
3. Association between homocysteine status and the risk of nephropathy in type 2 diabetes mellitus.
Mao S; Xiang W; Huang S; Zhang A
Clin Chim Acta; 2014 Apr; 431():206-10. PubMed ID: 24534450
[TBL] [Abstract][Full Text] [Related]
4. Serum TNF-α concentrations in type 2 diabetes mellitus patients and diabetic nephropathy patients: A systematic review and meta-analysis.
Chen YL; Qiao YC; Xu Y; Ling W; Pan YH; Huang YC; Geng LJ; Zhao HL; Zhang XX
Immunol Lett; 2017 Jun; 186():52-58. PubMed ID: 28414180
[TBL] [Abstract][Full Text] [Related]
5. Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials.
Mou X; Zhou DY; Zhou DY; Ma JR; Liu YH; Chen HP; Hu YB; Shou CM; Chen JW; Liu WH; Ma GL
PLoS One; 2016; 11(2):e0149513. PubMed ID: 26901047
[TBL] [Abstract][Full Text] [Related]
6. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY
Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
[TBL] [Abstract][Full Text] [Related]
7. [Urine TGF-beta1 concentration in patients with type II diabetes mellitus--prognostic values].
Paczek L; Kropiewnicka HE; Senatorski G; Bartłomiejczyk I
Pol Arch Med Wewn; 2002 Aug; 108(2):745-52. PubMed ID: 12476894
[TBL] [Abstract][Full Text] [Related]
8. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
9. Association Between Serum Irisin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis.
Wang R; Liu H
Horm Metab Res; 2021 May; 53(5):293-300. PubMed ID: 33962476
[TBL] [Abstract][Full Text] [Related]
10. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios.
Ren H; Shao Y; Ma X; Yang M; Liu Y; Wang Q
J Diabetes Complications; 2019 Jul; 33(7):477-484. PubMed ID: 31097304
[TBL] [Abstract][Full Text] [Related]
11. Activation of transforming growth factor-beta1 in diabetic kidney disease.
Hellmich B; Schellner M; Schatz H; Pfeiffer A
Metabolism; 2000 Mar; 49(3):353-9. PubMed ID: 10726914
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
Shaker OG; Sadik NA
Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
[TBL] [Abstract][Full Text] [Related]
13. Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes.
Wu J; Shao X; Lu K; Zhou J; Ren M; Xie X; Liu J; Xu Y; Ding Y; Shen X; Zhu C
Cell Physiol Biochem; 2017; 42(2):594-602. PubMed ID: 28954270
[TBL] [Abstract][Full Text] [Related]
14. PTPN2 Downregulation Is Associated with Albuminuria and Vitamin D Receptor Deficiency in Type 2 Diabetes Mellitus.
Zheng L; Zhang W; Li A; Liu Y; Yi B; Nakhoul F; Zhang H
J Diabetes Res; 2018; 2018():3984797. PubMed ID: 30246029
[TBL] [Abstract][Full Text] [Related]
15. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy.
Shiju TM; Mohan V; Balasubramanyam M; Viswanathan P
J Diabetes Complications; 2015 Apr; 29(3):400-6. PubMed ID: 25619588
[TBL] [Abstract][Full Text] [Related]
17. Sodium Bicarbonate Supplementation and Urinary TGF-
Raphael KL; Greene T; Wei G; Bullshoe T; Tuttle K; Cheung AK; Beddhu S
Clin J Am Soc Nephrol; 2020 Feb; 15(2):200-208. PubMed ID: 31974286
[TBL] [Abstract][Full Text] [Related]
18. Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy.
Korpinen E; Groop PH; Fagerudd JA; Teppo AM; Akerblom HK; Vaarala O
Diabet Med; 2001 Feb; 18(2):121-5. PubMed ID: 11251675
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β1 in children with diabetic nephropathy.
Sawires H; Botrous O; Aboulmagd A; Madani N; Abdelhaleem O
Pediatr Nephrol; 2019 Jan; 34(1):81-85. PubMed ID: 30136104
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
Chou ST; Tseng ST
Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
